Biogen
BIIB
BIIB
958 hedge funds and large institutions have $32B invested in Biogen in 2023 Q3 according to their latest regulatory filings, with 91 funds opening new positions, 331 increasing their positions, 343 reducing their positions, and 118 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $36B → $32B (-$3.99B)
22% less funds holding in top 10
Funds holding in top 10: 18 → 14 (-4)
23% less first-time investments, than exits
New positions opened: 91 | Existing positions closed: 118
Holders
958
Holding in Top 10
14
Calls
$575M
Puts
$517M
Top Buyers
| 1 | +$348M | |
| 2 | +$132M | |
| 3 | +$77.1M | |
| 4 |
VanEck Associates
New York
|
+$60.1M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$53.4M |
Top Sellers
| 1 | -$329M | |
| 2 | -$191M | |
| 3 | -$172M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$148M |
| 5 |
D.E. Shaw & Co
New York
|
-$146M |